Correlation between staging classification of aortic stenosis based on the extent of cardiac damage and platelet

Tomer Maller1, Sharon Bruoha2, Ranel Loutati1

  • 1Jesselson Integrated Heart Center, Shaare Zedek Medical Center Jerusalem and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

PubMed

Insights

Platelet indices, including mean platelet volume (MPV), correlate with cardiac damage severity in patients after transcatheter aortic valve implantation (TAVI). Higher MPV is linked to more advanced aortic stenosis stages, suggesting its role in disease progression.

Area of Science:

  • Cardiology
  • Hematology
  • Biomarkers

Background:

  • Platelets are crucial in aortic stenosis (AS) and after transcatheter aortic valve implantation (TAVI).
  • An echo-based staging system classifies severe AS patients by cardiac damage phenotype.
  • This study investigates the relationship between AS stages and platelet indices post-TAVI.

Purpose of the Study:

  • To correlate an echo-based staging system for aortic stenosis (AS) with platelet indices in patients following transcatheter aortic valve implantation (TAVI).
  • To identify platelet-related biomarkers associated with cardiac damage severity in post-TAVI patients.

Main Methods:

  • Prospective identification of severe AS patients undergoing TAVI, admitted to the intensive cardiac care unit (ICCU).
  • Patients were stratified into 5 stages (0-4) based on extra-valvular cardiac damage.
  • Baseline characteristics and complete blood counts, including mean platelet volume (MPV) and immature platelet fraction (IPF), were analyzed.

Main Results:

  • Higher mean MPV values correlated with increased AS staging (P=0.02).
  • Lower hemoglobin levels were also associated with higher AS stages (P=0.04).
  • Multivariate analysis identified MPV (OR=2.6) and BMI (OR=1.17) as independently correlated with higher AS stages (0-3).

Conclusions:

  • Mean platelet volume (MPV) and immature platelet fraction (IPF) showed a trend of increase in stages 0-3, with a decrease in stage 4, possibly due to bone marrow dysfunction.
  • Higher MPV and lower hemoglobin levels were independently associated with more severe stages (0-3) of aortic stenosis post-TAVI.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.9K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and clinical manifestations

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
3
Atherosclerosis II: Clinical manifestations and prevention01:27

Atherosclerosis II: Clinical manifestations and prevention

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
2
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3